
|Articles|July 1, 2004
VACCINE SLOWS MELANOMA
Antigenics Inc. has announced its experimental cancer vaccine Oncophage improved post-surgery results for patients with metastatic melanoma, with one of 18 patients remaining disease-free for almost 15 months.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
2
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
3
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
4
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
5











